Immune deviation as a strategy for schistosomiasis vaccines designed to prevent infection and egg-induced immunopathology

Microbes and Infection

Volumn 1, Issue 7, 1999, Pages 525-534

  Wynn, Thomas A ^a  

^a Immunobiol Sect Lab Parasitic D   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; MONOCLONAL ANTIBODY; NITRIC OXIDE; RECOMBINANT INTERLEUKIN 12; SCHISTOSOMA VACCINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; CERCARIA; CONTROLLED STUDY; EGG; EXPERIMENTAL MODEL; GRANULOMA; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LIVER GRANULOMA; LUNG GRANULOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; VACCINATION;

ANIMALIA; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 0032696176     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)80092-6     Document Type: Article

References (73)

1. Afonso L.C.C., Scharton T.M., Vieira L.Q., Wysocka M., Trinchieri G., Scott P. The adjuvant effect of interleukin 12 in a vaccine against Leishmania major. Science. 263:1993;235-237.
2. Amiri P., Locksley R.M., Parslow T.G., Sadick M., Rector E., Ritter D., McKerrow J.H. Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice [see comments]. Nature. 356:1992;604-607.
3. Asherson G.L., Stone S.H. Selective and specific inhibition of 24 hour skin reactions in the guinea-pig. I. Immune deviation: description of the phenomenon and the effect of splenectomy. Immunology. 9:1965;205-217.
4. Barata L.T., Ying S., Meng Q., Barkans J., Rajakulasingam K., Durham S.R., Kay A.B. IL-4- and IL-5-positive T lymphocytes, eosinophils and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Allergy Clin. Immunol. 101:1998;222-230.
5. Bergquist R. Prospects of vaccination against schistosomiasis. Scand. J. Infect. Dis. Suppl. 76:1990;60-71.
6. Brunet L.R., Finkelman F.D., Cheever A.W., Kopf M.A., Pearce E.J. IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis. J. Immunol. 159:1997;777-785.
7. Butterworth A.E., Capron M., Cordingley J.S., Dalton P.R., Dunne D.W., Kariuki H.C., Kimani G., Koech D., Mugambi M., Ouma J.H. Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals and analysis of their immune responses. Trans. R. Soc. Trop. Med. Hyg. 79:1985;393-408.
8. Butterworth A.E., Dunne D.W., Fulford A.J., Thorne K.J., Gachuhi K., Ouma J.H., Sturrock R.F. Human immunity to Schistosoma mansoni: observations on mechanisms and implications for control. Immunol. Invest. 21:1992;391-407.
9. Capron M., Capron A. Immunoglobulin E and effector cells in schistosomiasis. Science. 264:1994;1876-1877.
10. Caulada-Benedetti Z., Aal-Zamel F., Sher A., James S. Comparison of Th1- and Th2-associated immune reactivities stimulated by single versus multiple vaccination of mice with irradiated Schistosoma mansoni cercariae. J. Immunol. 146:1991;1655-1660.
11. Cheever A.W., Eltoum I.A., Andrade Z.A., Cox T.M. Biology and pathology of Schistosoma mansoni and Schistosoma japonicum infections in several strains of nude mice. Am. J. Trop. Med. Hyg. 48:1993;496-503.
12. Cheever A.W., Lewis F.A., Wynn T.A. Schistosoma mansoni: unisexual infections sensitized mice for granuloma formation around intravenously injected eggs. Parasitol. Res. 83:1997;57-59.
13. Cheever A.W., Williams M.E., Wynn T.A., Finkelman F.D., Seder R.A., Hieny S., Caspar P., Sher A. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J. Immunol. 153:1994;753-754.
14. Cheever A.W., Yap G.S. Immunologic basis of disease and disease regulation in schistosomiasis. Chem. Immunol. 66:1997;159-176.
15. + T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. J. Immunol. 159:1997;2240-2249.
16. Chen Y., Boros D.L. Identification of the immunodominant T cell epitope of p38 a major egg antigen and characterization of the epitope-specific Th responsiveness during murine schistosomiasis mansoni. J. Immunol. 160:1998;5420-5427.
17. Chensue S.W., Terebuh P.D., Warmington K.S., Hershey S.D., Evanoff H.L., Kunkel S.L., Higashi G.I. Role of interleukin-4 and gamma-interferon in Schistosoma mansoni egg-induced hypersensitivity granuloma formation: orchestration relative contribution and relationship to macrophage function. J. Immunol. 148:1992;900-910.
18. Chiaramonte M.G., Schopf L.R., Neben T.Y., Cheever A.W., Donaldson D.D., Wynn T.A. IL-13 is a key effector cytokine for T helper 2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J. Immunol. 162:1998;920-930.
19. Couissinier-Paris P., Dessein A.J. Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2. Eur. J. Immunol. 25:1995;2295-2302.
20. Coulson P.S., Smythies L.E., Betts C., Mabbott N.A., Sternberg J.M., Wei X.G., Liew F.Y., Wilson R.A. Nitric oxide produced in the lungs of mice immunized with the radiation-attenuated schistosome vaccine is not the major agent causing challenge parasite elimination. Immunology. 93:1998;55-63.
21. Czaja M.J., Weiner F.R., Takahashi S., Giambrone M.A., van derMeide P.H., Schellekens H., Biempica L., Zern M.A. γ-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology. 10:1993;795-800.
22. Dean D.A., Mangold B.L. Evidence that both normal and immune elimination of Schistosoma mansoni take place at the lung stage of migration prior to parasite death. Am. J. Trop. Med. Hyg. 47:1992;238-248.
23. Donaldson D.D., Whitters M.J., Fitz L., Neben T.Y., Finnerty H., Henderson S.L., O'HaraJr R.M., Beier D.R., Turner K.J., Wood C.R., Collins M. The murine IL-13Ra2: Molecular cloning characterization and comparison with Murine IL-13Ra1. J. Immunol. 161:1998;2317-2324.
24. Eltoum I.A., Wynn T.A., Poindexter R.W., Finkelman F.D., Lewis F.A., Sher A., Cheever A.W. Suppressive effect of interleukin-4 neutralization differs for granulomas around Schistosoma mansoni eggs injected into mice compared with those around eggs laid in infected mice. Infect. Immun. 63:1995;2532-2536.
25. Engers H.D., Bergquist R., Modabber F. Progress on vaccines against parasites. Dev. Biol. Stand. 87:1996;73-84.
26. Grzych J.M., Pearce E.J., Cheever A., Caulada Z.A., Caspar P., Heiny S., Lewis F., Sher A. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J. Immunol. 146:1991;1322-1327.
27. Hernandez H.J., Trzyna W.C., Cordingley J.S., Brodeur P.H., Stadecker M.J. Differential antigen recognition by T cell populations from strains of mice developing polar forms of granulomatous inflammation in response to eggs of Schistosoma mansoni. Eur. J. Immunol. 27:1997;666-670.
28. Hoffmann K.F., Caspar P., Cheever A.W., Wynn T.A. IFN-γ IL-12 and TNF-a are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12. J. Immunol. 161:1998;4201-4210.
29. James S.L. Role of nitric oxide in parasitic infections. Microbiol. Rev. 59:1995;533-547.
30. James S.L., Cheever A.W., Caspar P., Wynn T.A. Inducible nitric oxide synthase-deficient mice develop enhanced type 1 cytokine-associated cellular and humoral immune responses after vaccination with attenuated Schistosoma mansoni cercariae but display partially reduced resistance. Infect. Immun. 66:1998;3510-3518.
31. James S.L., Glaven J. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J. Immunol. 143:1989;4208-4212.
32. James S.L., Skamene E., Meltzer M.S. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection. J. Immunol. 131:1983;948-953.
33. Kaplan M.H., Whitfield J.R., Boros D.L., Grusby M.J. Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J. Immunol. 160:1998;1850-1856.
34. Kassim O.O., Dean D.A., Mangold B.L., Von Lichtenberg F. Combined microautoradiographic and histopathologic analysis of the fate of challenge Schistosoma mansoni schistosomula in mice immunized with irradiated cercariae. Am. J. Trop. Med. Hyg. 47:1992;231-237.
35. Kobayashi M., Fitz L., Ryan M., Hewick R.M., Clark S.C., Chan S., Loudon R., Sherman F., Perussia B., Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF) a cytokine with multiple biologic effects on human lymphocytes. J. Exp. M. 170:1989;827-845.
36. Leptak C.L., McKerrow J.H. Schistosome egg granulomas and hepatic expression of TNF-alpha are dependent on immune priming during parasite maturation. J. Immunol. 158:1997;301-307.
37. Lukacs N.W., Boros D.L. Identification of larval cross-reactive and egg-specific antigens involved in granuloma formation in murine schistosomiasis mansoni. Infect. Immun. 59:1991;3237-3242.
38. Maclean A., Wei X.Q., Huang F.P., Al-Alem U.A., Chan W.L., Liew F.Y. Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. J. Gen. Virol. 79:1998;825-830.
39. Macmicking J.D., Nathan C., Hom G., Chartrain N., Fletcher D.S., Trumbauer M., Stevens K., Xie Q.W., Sokol K., Hutchinson N. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase [published erratum appears in Cell (1995) Jun 30; 81 (7): following 1170]. Cell. 81:1995;641-650.
40. Mangold B.L., Dean D.A. Passive transfer with serum and IgG antibodies of irradiated cercaria-induced resistance against Schistosoma mansoni in mice. J. Immunol. 136:1986;2644-2648.
41. McInnes I.B., Leung B., Wei X.Q., Gemmell C.C., Liew F.Y. Septic arthritis following Staphylococcus aureus infection in mice lacking inducible nitric oxide synthase. J. Immunol. 160:1998;308-315.
42. Metwali A., Elliott D., Blum A.M., Li J., Sandor M., Lynch R., Noben-Trauth N., Weinstock J.V. The granulomatous response in murine Schistosomiasis mansoni does not switch to Th1 in IL-4-deficient C57BL/6 mice. J. Immunol. 157:1996;4546-4553.
43. Minard P., Dean D.A., Jacobson R.H., Vannier W.E., Murrell K.D. Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercariae. Am. J. Trop. Med. Hyg. 27:1978;76-86.
44. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1 Th2 and more. Immunol. Today. 17:1996;138-146.
45. Mountford A.P., Anderson S., Wilson R.A. Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant. J. Immunol. 156:1996;4739-4745.
46. Mwatha J.K., Kimani G., Kamau T., Mbugua G.G., Ouma J.H., Mumo J., Fulford A.J., Jones F.M., Butterworth A.E., Roberts M.B., Dunne D.W. High levels of TNF soluble TNF receptors soluble ICAM-1 and IFN-gamma but low levels of IL-5 are associated with hepatosplenic disease in human schistosomiasis mansoni. J. Immunol. 160:1998;1992-1999.
47. Oswald I.P., Gazzinelli R.T., Sher A., James S.L. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J. Immunol. 148:1992;3578-3582.
48. Pearce E.J., Caspar P., Grzych J.M., Lewis F.A., Sher A. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth Schistosoma mansoni. J. Exp. M. 173:1992;159-162.
49. Pearce E.J., Cheever A., Leonard S., Covalesky M., Fernandez-Botran R., Kohler G., Kopf M. Schistosoma mansoni in IL-4-deficient mice. Int. Immunol. 8:1996;435-444.
50. Pearce E.J., Reiner S.L. Induction of Th2 responses in infectious diseases. Curr. Opin. Immunol. 7:1995;497-504.
51. Sabin E.A., Kopf M.A., Pearce E.J. Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J. Exp. M. 184:1996;1871-1878.
52. Sher A., Coffman R.L., Hieny S., Cheever A.W. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J. Immunol. 145:1990;3911-3916.
53. Smythies L.E., Coulson P.S., Wilson R.A. Monoclonal antibody to IFN-gamma modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. J. Immunol. 149:1992;3654-3658.
54. Smythies L.E., Coulson P.S., Wilson R.A. Immunity to Schistosoma mansoni in mice vaccinated with irradiated cercariae: cytokine interactions in the pulmonary protective response. Ann. Trop. Med. Parasitol. 87:1993;653-657.
55. Stadecker M.J., Kamisato J.K., Chikunguwo S.M. Induction of T helper cell unresponsiveness to antigen by macrophages from schistosomal egg granulomas. A basis for immunomodulation in schistosomiasis? J. Immunol. 145:1990;2697-2700.
56. + Th2 response induced by Schistosoma mansoni eggs develops rapidly through an early transient Th0-like stage. J. Immunol. 148:1992;2283-2288.
57. + thymocytes. Eur. J. Immunol. 26:1996;1424-1429.
58. + T cells in immunity to Schistosoma mansoni induced by 20 krad-irradiated and Ro11-3128-terminated infections. Immunology. 67:1989;466-472.
59. von Lichtenberg F.C. Host response to eggs of S. mansoni. I. Granuloma formation in the unsensitized laboratory mouse. Am. J. Trop. Med. Hyg. 41:1962;711-731.
60. Webster M., Fulford A.J., Braun G., Ouma J.H., Kariuki H.C., Havercroft J.C., Gachuhi K., Sturrock R.F., Butterworth A.E., Dunne D.W. Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatment. Infect. Immun. 64:1996;4042-4046.
61. Wei X.Q., Charles I.G., Smith A., Ure J., Feng G.J., Huang F.P., Xu D., Muller W., Moncada S., Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
62. Williams M.E., Kullberg M.C., Barbieri S., Caspar P., Berzofsky J.A., Seder R.A., Sher A. Fc epsilon receptor-positive cells are a major source of antigen- induced interleukin-4 in spleens of mice infected with Schistosoma mansoni. Eur. J. Immunol. 23:1993;1910-1916.
63. Wilson R.A., Coulson P.S., Betts C., Dowling M.A., Smythies L.E. Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine. Immunology. 87:1996;275-282.
64. Wynn T.A., Cheever A.W., Jankovic D., Poindexter R.W., Caspar P., Lewis F.A., Sher A. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature. 376:1995;594-596.
65. Wynn T.A., Eltoum I., Cheever A.W., Lewis F.A., Gause W.C., Sher A. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J. Immunol. 151:1993;1430-1440.
66. Wynn T.A., Eltoum I., Oswald I.P., Cheever A.W., Sher A. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. M. 179:1994;1551-1561.
67. Wynn T.A., Jankovic D., Hieny S., Zioncheck K., Jardieu P., Cheever A.W., Sher A. IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-gamma. J. Immunol. 154:1995;3999-4009.
68. Wynn T.A., Jankovic D., Hieny S., Cheever A.W., Sher A. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression IgE production and tissue eosinophilia. J. Immunol. 154:1995;4701-4709.
69. Wynn T.A., Morawetz R., Scharton-Kersten T., Hieny S., Morse H.C.R., Kuhn R., Muller W., Cheever A.W., Sher A. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. J. Immunol. 159:1997;5014-5023.
70. Wynn T.A., Oswald I.P., Eltoum I.A., Caspar P., Lowenstein C.J., Lewis F.A., James S.L., Sher A. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J. Immunol. 153:1994;5200-5209.
71. Wynn T.A., Reynolds A., James S., Cheever A.W., Caspar P., Hieny S., Jankovic D., Strand M., Sher A. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J. Immunol. 157:1996;4068-4078.
72. Xu C.B., Verwaerde C., Grzych J.M., Fontaine J., Capron A. A monoclonal antibody blocking the Schistosoma mansoni 28-kDa glutathione S-transferase activity reduces female worm fecundity and egg viability. Eur. J. Immunol. 21:1991;1801-1807.
73. Zurawski G., deVries J.E. Interleukin 13 elicits a subset of the activities of its close relative interleukin 4. Stem Cells (Dayt). 12:1994;169-174.